<DOC>
	<DOCNO>NCT00827255</DOCNO>
	<brief_summary>The objective retrospective chart review evaluate patient characteristic , treatment variation efficacy second trial Cyclosporine Ophthalmic Emulsion 0.05 % therapy chronic dry eye patient initially treat Cyclosporine Ophthalmic Emulsion 0.05 % discontinue use less 12 week treatment .</brief_summary>
	<brief_title>Physician 's Evaluation Cyclosporine Ophthalmic Emulsion 0.05 %</brief_title>
	<detailed_description />
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Adults &gt; 16 year age Dry eye patient Subject history le 12 week initial RESTASIS® treatment Subject start second trial RESTASIS® treatment prior June 1 , 2008 First day second trial RESTASIS® start ≥ 4 week last day previous RESTASIS® treatment Patients Contact Lens Intolerance Patients Ocular Rosacea</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>